218 related articles for article (PubMed ID: 30940667)
21. Thrombotic Management of Antiphospholipid Syndrome: Towards Novel Targeted Therapies.
Islam MA; Alam F; Wong KK; Kamal MA; Gan SH
Curr Vasc Pharmacol; 2017; 15(4):313-326. PubMed ID: 28056758
[TBL] [Abstract][Full Text] [Related]
22. Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndrome.
Williams B; Saseen JJ; Trujillo T; Palkimas S
J Thromb Thrombolysis; 2022 Jul; 54(1):67-73. PubMed ID: 34817786
[TBL] [Abstract][Full Text] [Related]
23. Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin
.
Adachi T; Hoshino H; Takagi M; Fujioka S;
Cerebrovasc Dis Extra; 2017; 7(1):62-71. PubMed ID: 28376486
[TBL] [Abstract][Full Text] [Related]
24. Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism - The SWAN Study.
Hendriks T; McGregor S; Rakesh S; Robinson J; Ho KM; Baker R
PLoS One; 2020; 15(6):e0234048. PubMed ID: 32497116
[TBL] [Abstract][Full Text] [Related]
25. Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials.
Dufrost V; Wahl D; Zuily S
Autoimmun Rev; 2021 Jan; 20(1):102711. PubMed ID: 33197580
[TBL] [Abstract][Full Text] [Related]
26. The management of thrombosis in the antiphospholipid-antibody syndrome.
Khamashta MA; Cuadrado MJ; Mujic F; Taub NA; Hunt BJ; Hughes GR
N Engl J Med; 1995 Apr; 332(15):993-7. PubMed ID: 7885428
[TBL] [Abstract][Full Text] [Related]
27. The use of rivaroxaban in patients with antiphospholipid syndrome: A series of 12 cases.
Son M; Wypasek E; Celinska-Lowenhoff M; Undas A
Thromb Res; 2015 May; 135(5):1035-6. PubMed ID: 25669601
[No Abstract] [Full Text] [Related]
28. Recurrent Thrombosis in Patients with Antiphospholipid Syndrome Receiving Newer Oral Anticoagulants: A Case Report and Review of Literature.
Joshi A; Hong J; Siva C
Clin Med Res; 2017 Jun; 15(1-2):41-44. PubMed ID: 28751467
[TBL] [Abstract][Full Text] [Related]
29. Antiphospholipid antibody syndrome: recent findings on managing this challenging condition.
Crowther MA
Cleve Clin J Med; 2005 Mar; 72(3):245-9. PubMed ID: 15825803
[TBL] [Abstract][Full Text] [Related]
30. Cerebral Venous Thromboembolism in Antiphospholipid Syndrome Successfully Treated with the Combined Use of an Anti-Xa Inhibitor and Corticosteroid.
Sugie M; Iizuka N; Shimizu Y; Ichikawa H
Intern Med; 2015; 54(23):3051-6. PubMed ID: 26631891
[TBL] [Abstract][Full Text] [Related]
31. Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis.
Dufrost V; Risse J; Reshetnyak T; Satybaldyeva M; Du Y; Yan XX; Salta S; Gerotziafas G; Jing ZC; Elalamy I; Wahl D; Zuily S
Autoimmun Rev; 2018 Oct; 17(10):1011-1021. PubMed ID: 30103045
[TBL] [Abstract][Full Text] [Related]
32. Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure.
Pengo V; Hoxha A; Andreoli L; Tincani A; Silvestri E; Prisco D; Fierro T; Gresele P; Cafolla A; De Micheli V; Ghirarduzzi A; Tosetto A; Falanga A; Martinelli I; Testa S; Barcellona D; Gerosa M; Denas G
J Thromb Haemost; 2021 Feb; 19(2):531-535. PubMed ID: 33128325
[TBL] [Abstract][Full Text] [Related]
33. Oral anticoagulation cost in primary antiphospholipid syndrome: comparison between warfarin and hypothetical rivaroxaban.
Ciampa A; Salapete C; Vivolo S; Ames PRJ
Blood Coagul Fibrinolysis; 2018 Jan; 29(1):135-138. PubMed ID: 29095760
[TBL] [Abstract][Full Text] [Related]
34. Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem?
Balaban M; Stanrić V; Rincić G; Ledinsky M; Grbac L; Stancić N; Tomasić H
Acta Clin Croat; 2010 Dec; 49(4):469-77. PubMed ID: 21830460
[TBL] [Abstract][Full Text] [Related]
35. What is the appropriate anticoagulation strategy for thrombotic antiphospholipid syndrome?
Arachchillage DRJ; Laffan M
Br J Haematol; 2020 Apr; 189(2):216-227. PubMed ID: 32108324
[TBL] [Abstract][Full Text] [Related]
36. Current management of antiphospholipid syndrome-related thrombosis.
Puente D; Pombo G; Forastiero R
Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1551-8. PubMed ID: 19954317
[TBL] [Abstract][Full Text] [Related]
37. Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban.
Ferreira T; Huber SC; de Moraes Martinelli B; Junior AL; Menezes FH; Orsi FA; Bittar LF; de Oliveira LFG; Sodre LR; Mello TT; Rielli G; Colella MP; de Paula EV; Yamaguti-Hayakawa GG; Montalvão S; Annichino-Bizzacchi JM
Vascul Pharmacol; 2020 Jan; 124():106608. PubMed ID: 31678199
[TBL] [Abstract][Full Text] [Related]
38. Antiphospholipid antibody syndrome-associated renal thrombotic microangiopathy improved not with rivaroxaban but with warfarin in a systemic lupus erythematosus patient without lupus nephritis.
Horita S; Zoshima T; Hara S; Koichi M; Hirayama S; Suzuki K; Nakashima A; Kawano M
CEN Case Rep; 2021 Aug; 10(3):409-413. PubMed ID: 33595828
[TBL] [Abstract][Full Text] [Related]
39. Thrombotic events in patients with antiphospholipid syndrome treated with rivaroxaban: a series of eight cases.
Signorelli F; Nogueira F; Domingues V; Mariz HA; Levy RA
Clin Rheumatol; 2016 Mar; 35(3):801-5. PubMed ID: 26219490
[TBL] [Abstract][Full Text] [Related]
40. Rivaroxaban Concentration in Breast Milk During Breastfeeding: A Case Study.
Saito J; Kaneko K; Yakuwa N; Kawasaki H; Yamatani A; Murashima A
Breastfeed Med; 2019 Dec; 14(10):748-751. PubMed ID: 31746638
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
